SynthesisPharmacology research & perspectives2021

A meta-analysis and cost-minimization analysis of bivalirudin versus heparin in high-risk patients for percutaneous coronary intervention.

Ke-Xin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.